Douglas J. Manion - Net Worth and Insider Trading
Douglas J. Manion Net Worth
The estimated net worth of Douglas J. Manion is at least $15,616 dollars as of 2024-05-10. Douglas J. Manion is the Pres and CEO of Aclaris Therapeutics Inc and owns about 12,800 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $15,616. Details can be seen in Douglas J. Manion's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas J. Manion has not made any transactions after 2023-03-17 and currently still holds the listed stock(s).
Transaction Summary of Douglas J. Manion
Douglas J. Manion Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas J. Manion owns 1 companies in total, including Aclaris Therapeutics Inc (ACRS) .
Click here to see the complete history of Douglas J. Manion’s form 4 insider trades.
Insider Ownership Summary of Douglas J. Manion
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2023-03-17 | Pres and COO |
Douglas J. Manion Latest Holdings Summary
Douglas J. Manion currently owns a total of 1 stock. Douglas J. Manion owns 12,800 shares of Aclaris Therapeutics Inc (ACRS) as of March 17, 2023, with a value of $15,616.
Latest Holdings of Douglas J. Manion
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2023-03-17 | 12,800 | 1.22 | 15,616 |
Holding Weightings of Douglas J. Manion
Douglas J. Manion Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas J. Manion has made a total of 2 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aclaris Therapeutics Inc is the acquisition of 6,300 shares on March 17, 2023, which cost Douglas J. Manion around $49,518.
Insider Trading History of Douglas J. Manion
- 1
Douglas J. Manion Trading Performance
GuruFocus tracks the stock performance after each of Douglas J. Manion's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas J. Manion is 26.06%. GuruFocus also compares Douglas J. Manion's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas J. Manion within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas J. Manion's insider trading performs compared to the benchmark.
Performance of Douglas J. Manion
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.18 | | | | | |
| Relative Return to S&P 500(%) | 14.8 | | | | | |
Douglas J. Manion Ownership Network
Douglas J. Manion Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Douglas J. Manion is the Pres and COO of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Douglas J. Manion made 2 insider transaction in Aclaris Therapeutics Inc (ACRS) with a net purchase of 12,800. Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 10,438 shares made by James Loerop .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Douglas J. Manion Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas J. Manion. You might contact Douglas J. Manion via mailing address: C/o Aclaris Therapeutics, Inc., 640 Lee Road, Suite 200, Wayne Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
